J. K. Baird

Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.

M. Bangs, J. Maguire, C. Sibley, 2004, The Journal of infectious diseases.

Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis

L. Seidlein, Richard N. Price, N. Valecha, 2014, The Lancet. Infectious diseases.

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs

R. Price, K. Kypri, Trevor van Mierlo, 2007, Malaria Journal.

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis.

N. Anstey, K. Stepniewska, T. William, 2023, The Lancet. Infectious diseases.

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

B. Ley, K. Thriemer, Richard N. Price, 2023, BMC Medical Research Methodology.

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial

B. Ley, K. Thriemer, Richard N. Price, 2023, The Lancet.

Towards harmonization of microscopy methods for malaria clinical research studies

R. Price, M. Gatton, J. Barnwell, 2020, Malaria journal.